Suwa Y, Kudo I, Imaizumi A, Okada M, Kamimura T, Suzuki Y, Chang H W, Hara S, Inoue K
Teijin Institute for Biomedical Research, Tokyo, Japan.
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2395-9. doi: 10.1073/pnas.87.7.2395.
We have purified two phospholipase A2 inhibitory proteins (37 and 33 kDa) from peritoneal fluid of dexamethasone-treated rats. The extracellular phospholipase A2 found in inflammatory sites differed from the exocrine phospholipase A2 in susceptibility to these endogenous inhibitors; both proteins inhibited the activity of the extracellular phospholipase A2 purified from sites of inflammation but did not affect appreciably the activity of either porcine pancreatic or Naja naja venom phospholipase A2. The amino acid sequence of the NH2-terminal portion of the purified proteins did not resemble that of lipocortins so far reported, but it was almost identical to that of parts of human or mouse complement component C3. These findings may indicate that degraded products of C3 are involved in the regulation of activity of a class of mammalian phospholipase A2.
我们从地塞米松处理过的大鼠的腹腔液中纯化出了两种磷脂酶A2抑制蛋白(37 kDa和33 kDa)。在炎症部位发现的细胞外磷脂酶A2,在对内源抑制剂的敏感性方面与外分泌磷脂酶A2不同;这两种蛋白都抑制从炎症部位纯化出的细胞外磷脂酶A2的活性,但对猪胰磷脂酶A2或眼镜蛇毒磷脂酶A2的活性没有明显影响。纯化蛋白的NH2末端部分的氨基酸序列与迄今报道的脂皮质素的序列不同,但与人类或小鼠补体成分C3的部分序列几乎相同。这些发现可能表明C3的降解产物参与了一类哺乳动物磷脂酶A2活性的调节。